Share

June 05, 2012; 78 (23) Articles

Nutrient intake and plasma β-amyloid

Y. Gu, N. Schupf, S.A. Cosentino, J.A. Luchsinger, N. Scarmeas
First published May 2, 2012, DOI: https://doi.org/10.1212/WNL.0b013e318258f7c2
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
788

Share

This article has a correction. Please see:

Article Information

vol. 78 no. 23 1832-1840
DOI: 
https://doi.org/10.1212/WNL.0b013e318258f7c2
PubMed: 
22551728
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received August 19, 2011
  • Accepted January 31, 2012
  • First Published May 2, 2012.

Article Versions

Copyright & Usage: 
Copyright © 2012 by AAN Enterprises, Inc.

Author Disclosures

    1. Y. Gu, PhD,
    2. N. Schupf, PhD,
    3. S.A. Cosentino, PhD,
    4. J.A. Luchsinger, MD and
    5. N. Scarmeas, MD
  1. Y. Gu, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. N. Schupf, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. New York Methodist Hospital, Honorarium

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Janssen Alzheimer Immunology R&D LLC

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. support from NIH #R01AG014673(PI),(2005-2011) NIH #P01HD035897(Co-I), (2010 - 2015) NIH #R01AG037212 (Co-PI), (2010-2015) NIH #R01AG028786(Co-I), (2007 - 2012) NIH #U01 AG023749 (Co-I),(2010 - 2013) NIH #P50 AG08702 (Co-I), (201--2015) NIH #R01AG007370 (Co-I), (2006-2011) NIH #R21CA125461(Co-I), (2009-2011) NIH #R01AG036040 (Co-I), (2009-2014) NIH #AG034189 (Co-I) (2010-2015) NIH DP3DK094400 (Co-I) (2011-2015

    Research Support, Academic Entities:

    1. NYS Institute for Basic Research in Developmental Disabilities

    Research Support, Foundations and Societies:

    1. Alzheimer’s Association IIRG-08-90655 (PI) (2008-2011) Alzheimer’s Association #IIRG-08-92010 (Co-I)(2008-2011)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. S.A. Cosentino, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH NIA: K23 AG032899, PI, 2008-2013

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Association for Frontotemporal Degeneration

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. J.A. Luchsinger, MD and
    5. Scientific Advisory Boards:

    1. Commercial: Nutricia, Inc; Non-commercial: Pennington Research Institute, LSU

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal of Alzheimer’s Disease

    Patents:

    1. NONE

    Publishing Royalties:

    1. Biessels GJ, Luchsinger JA. Diabetes and the Brain. Humana Press 2009. Received $509.78 on 04/28/2010

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1) NIMHD; P60 MD000206;principal investigator; 02/01/07-01/31/13 2) NIA; RO1 AG026413; principal investigator; 05/01/08-04/30/12 3) NIDDK; U01DK048404; co-investigator; 07/01/09-06/30/14 4) NIA; R01 AG028506; co-investigator; 03/01/08-02/28/13 6) NICHD; P01HD35897-22 A1; co-investigator; 7/01/09 - 06/30/14 7) NIA; 1R01AG037212-01; co-investigator; 04/01/10-03/31/15 8) NIA; 1R01AG034189; co-investigator ; 04/01/10-03/31/15 9) NIMHD; MD000206-08S1; principal investigator; 09/18/10-09/17/12

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Institute for the Study of Aging: Grant # 270901 American Diabetes Association 7-08-CR-41 Alzheimer’s Association (IIRG-05-15053)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. N. Scarmeas, MD
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Federal NIA grant AG028506

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Alzheimer’s Association grant IIRG-04-1353

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Taub Institute for Research in Alzheimer's Disease and the Aging Brain (Y.G., N.S., S.A.C., J.A.L., N.S.), Gertrude H. Sergievsky Center (N.S., S.A.C., J.A.L., N.S.), Division of Epidemiology, Joseph P. Mailman School of Public Health (N.S.), Department of Neurology (S.A.C., N.S.), and Department of Medicine (J.A.S.), Columbia University, New York, NY.
  1. Correspondence & reprint requests to Dr. Scarmeas: ns257{at}columbia.edu
View Full Text

Article usage

Article usage: May 2012 to August 2023

AbstractFullPdfSource
May 201252451155Highwire
Jun 201221153470Highwire
Jul 2012704918Highwire
Aug 20125571725Highwire
Sep 20124251325Highwire
Oct 201234878Highwire
Nov 2012224128Highwire
Dec 2012211913Highwire
Jan 201316976Highwire
Feb 201315056Highwire
Mar 201325735Highwire
Apr 201323562Highwire
May 201321654Highwire
Jun 2013192911Highwire
Jul 201320824Highwire
Aug 201313922Highwire
Sep 201326010Highwire
Oct 201317233Highwire
Nov 201316034Highwire
Dec 201315700Highwire
Jan 201416901Highwire
Jan 201403419pmc
Feb 201413111Highwire
Mar 201421000Highwire
Apr 201411800Highwire
May 201413043Highwire
Jun 201410120Highwire
Jul 20149101Highwire
Aug 20149700Highwire
Sep 201412730Highwire
Oct 201412311Highwire
Nov 201411611Highwire
Dec 201412312Highwire
Jan 201514311Highwire
Jan 2015068pmc
Feb 201523200Highwire
Feb 201502012pmc
Mar 201514300Highwire
Mar 201502715pmc
Apr 20159800Highwire
Apr 201502318pmc
May 201513510Highwire
May 20150149pmc
Jun 201510522Highwire
Jun 201501611pmc
Jul 201512600Highwire
Jul 20150139pmc
Aug 201511511Highwire
Aug 20150365pmc
Sep 201511852Highwire
Sep 20150116pmc
Oct 20159411Highwire
Oct 201502110pmc
Nov 20157712Highwire
Nov 2015076pmc
Dec 20158912Highwire
Dec 2015066pmc
Jan 201610500Highwire
Jan 20160138pmc
Feb 20166900Highwire
Feb 20160184pmc
Mar 20166522Highwire
Mar 20160102pmc
Apr 20167201Highwire
Apr 20160106pmc
May 20169601Highwire
May 20160158pmc
Jun 20168700Highwire
Jun 20160106pmc
Jul 20169400Highwire
Jul 2016095pmc
Aug 20167000Highwire
Aug 2016079pmc
Sep 20169500Highwire
Sep 20160139pmc
Oct 201610600Highwire
Oct 201601110pmc
Nov 20167700Highwire
Nov 20160147pmc
Dec 20166701Highwire
Dec 201601612pmc
Jan 20179711Highwire
Jan 20170146pmc
Feb 20177600Highwire
Feb 20170115pmc
Mar 20177501Highwire
Mar 20170122pmc
Apr 20178437Highwire
Apr 201791620pmc
May 20177800Highwire
May 201741113pmc
Jun 20175800Highwire
Jun 2017466pmc
Jul 20175800Highwire
Jul 2017388pmc
Aug 20175800Highwire
Aug 2017256pmc
Sep 20175732Highwire
Sep 20173913pmc
Oct 20177412Highwire
Oct 2017377pmc
Nov 20175800Highwire
Nov 20174713pmc
Dec 20175710Highwire
Jan 20187801Highwire
Feb 20188311Highwire
Mar 20188400Highwire
Apr 20188900Highwire
Apr 2018244pmc
May 20187200Highwire
Jun 20187600Highwire
Jun 201841216pmc
Jul 20186500Highwire
Aug 20187700Highwire
Aug 201851610pmc
Sep 20186600Highwire
Oct 20188400Highwire
Nov 201810700Highwire
Dec 20189200Highwire
Jan 20197000Highwire
Feb 20195600Highwire
Mar 20192500Highwire
Apr 20198100Highwire
May 20193000Highwire
Jun 20191900Highwire
Jul 20193310Highwire
Aug 20192710Highwire
Sep 20192000Highwire
Oct 20193000Highwire
Nov 20194100Highwire
Dec 20196602Highwire
Jan 20203300Highwire
Feb 20203300Highwire
Mar 20202300Highwire
Apr 20205900Highwire
May 20202000Highwire
Jun 20203531Highwire
Jul 20205800Highwire
Aug 202010701Highwire
Sep 20209700Highwire
Oct 20207121Highwire
Nov 20205210Highwire
Dec 20204211Highwire
Jan 202111944Highwire
Feb 202112131Highwire
Mar 20218022Highwire
Apr 20218021Highwire
May 20218100Highwire
Jun 20216330Highwire
Jul 20218220Highwire
Aug 20216000Highwire
Sep 20214520Highwire
Oct 20213610Highwire
Nov 20215010Highwire
Dec 20215221Highwire
Jan 20227021Highwire
Feb 20226311Highwire
Mar 202212132Highwire
Apr 202211300Highwire
May 202210001Highwire
Jun 20228900Highwire
Jul 20228401Highwire
Aug 20229811Highwire
Sep 20228431Highwire
Oct 20228321Highwire
Nov 20227900Highwire
Dec 20229600Highwire
Jan 20234520Highwire
Feb 20235311Highwire
Mar 20234010Highwire
Apr 20238751Highwire
May 20234000Highwire
Jun 20232911Highwire
Jul 20236320Highwire
Aug 20234432Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles